Loading...
XASX
IDT
Market cap11mUSD
Oct 09, Last price  
0.04AUD
1D
2.70%
1Q
18.75%
Jan 2017
-78.89%
Name

IDT Australia Ltd

Chart & performance

D1W1MN
XASX:IDT chart
P/E
—
P/S
0.80
EPS
—
Div yield, %
—
Shrs. gr., 5y
11.14%
Rev. gr., 5y
4.95%
Revenues
20m
+3.00%
26,298,00030,871,00026,423,00011,825,00012,770,0009,808,00010,593,00013,374,00015,720,0007,610,0009,543,00012,892,00012,130,00014,102,00015,989,00012,105,0006,935,00013,226,00019,765,00020,357,000
Net income
-3m
L-66.30%
5,467,0007,110,0006,416,000-1,577,000-236,000-1,837,000-5,354,000-6,626,000-2,992,000-4,006,000-773,000-16,979,000-6,083,000-1,919,0002,103,000-1,160,000-8,498,000-5,413,000-8,063,000-2,717,000
CFO
1m
P
8,740,00010,329,0009,423,0003,809,0003,203,000407,000-1,182,000-1,576,000-1,786,000-2,825,0002,019,000-1,627,000-1,516,000-1,888,000370,0002,861,000-7,902,000-9,602,000-6,252,0001,071,000
Dividend
Apr 12, 20100.0097 AUD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

IDT Australia Limited is an enterprise deeply involved in the entire lifecycle of pharmaceutical products, from initial research and development through to manufacturing and global distribution of both active pharmaceutical ingredients (APIs) and finished dosage forms. The company furnishes comprehensive analytical support, including the establishment of testing methodologies, stability assessments utilizing specialized chambers, and quality control laboratory services for both chemical and microbiological applications. Furthermore, its service offerings span project management, chemical processing, advanced analytical chemistry, pharmacy support, clinical trial packaging, and regulatory compliance assistance, alongside pharmaceutical development expertise across diverse dosage forms. Notably, IDT Australia also provides medicinal cannabis products and a broad array of contract manufacturing solutions. Established in 1975, the firm is headquartered in Boronia, Australia.

Key people

Executive Chairman of the Board · since 2025
Paul Mcdonald
Chief Executive Officer · since 2023
Mahendran Vasanthakumar
Interim Chief Financial Officer · since 2022
Chris Kagiaros
Head of People and Culture · since 2021
Mark Licciardo
Company Secretary · since 2022
Hugh Burrill
Non-Executive Independent Director · since 2015
Jane Ryan
Non-Executive Independent Director · since 2022
Independent Non-Executive Director · since 2022
IPO date
Mar 22, 1988
Employees
156
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑062025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT